Entries by CAPTIS

Sinovac Covid-19 vaccine collaboration with Butantan receives approval from Brazilian regulator for phase III trial

On July 3, 2020, the Brazilian National Regulatory Agency, Anvisa, granted approval to a phase III clinical trial sponsored by Instituto Butantan to test efficacy and safety of The post Sinovac Covid-19 vaccine collaboration with Butantan receives approval from Brazilian regulator for phase III trial appeared first on Pharmaceutical Business review.

EUSA Pharma gets FDA nod for phase 3 Covid-19 trial for Siltuximab

Siltuximab is a monoclonal antibody that directly neutralizes interleukin (IL)-6, an inflammatory cytokine detected at elevated levels in multiple inflammatory conditions, including COVID-19. It specifically binds to IL-6, The post EUSA Pharma gets FDA nod for phase 3 Covid-19 trial for Siltuximab appeared first on Pharmaceutical Business review.